Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M1UA
|
||||
Former ID |
DIB020295
|
||||
Drug Name |
lysophosphatidylinositol
|
||||
Synonyms |
LPI; L-alpha-lysophosphatidylinositol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540631] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H21O12P
|
||||
InChI |
InChI=1S/C11H21O12P/c1-4(12)21-2-5(13)3-22-24(19,20)23-11-9(17)7(15)6(14)8(16)10(11)18/h5-11,13-18H,2-3H2,1H3,(H,19,20)/t5-,6-,7-,8+,9+,10+,11-/m0/s1
|
||||
InChIKey |
FBDBXJJQMHPGMP-IFUOQLDVSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [527346] | |
TRPV2 | Target Info | Activator | [530038] | ||
G-protein coupled receptor 55 | Target Info | Agonist | [532227] | ||
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
References | |||||
Ref 527346 | Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun. 2005 Jan 28;326(4):744-51. | ||||
Ref 530038 | Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta. 2009 Mar;1793(3):528-39. | ||||
Ref 532227 | Screening beta-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J Biomol Screen. 2013 Jun;18(5):599-609. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.